CEO and Co-founder
Rebecca has over 15 years of experience in strategic investments, mergers & acquisitions, in- and out-licensing, and business development in both high-tech and life sciences.
Before founding Quickbeam, Rebecca was the VP of business development for ApeX Therapeutics, a startup biotech with a portfolio of anti-cancer therapeutics out of Indianapolis, Indiana. Her employers prior to ApeX include a life sciences venture capital fund, Cadence Design Systems, and Intel Capital.
Rebecca has a BA from Swarthmore College and an MBA from Duke University.
Pharmacotherapeutics for the treatment of methamphetamine addiction
COO and Co-founder
David has over 15 years of business development and strategic planning in the healthcare and management consulting industries
Prior to Quickbeam, David was director of strategic development for WebMD, where he managed key accounts with multiple large pharmaceutical and biotech companies. His client work included planning blockbuster drug launches on the WebMD platform.
David has a BA from Swarthmore College and an MBA and MPP from the University of Michigan.
© 2015 | Quickbeam, Inc.